Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Briggs

Showing results (91-100 of 94) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 94 results.
Trials|August 7, 2019
Update to the study protocol, including statistical analysis plan, for the multicentre, randomised controlled OuTSMART trial: a combined screening/treatment programme to prevent premature failure of renal transplants due to chronic rejection in patients with HLA antibodiesDominic Stringer, Leanne M Gardner, Janet L Peacock, et al.
Eclinicalmedicine|January 23, 2023
Optimized immunosuppression to prevent graft failure in renal transplant recipients with HLA antibodies (OuTSMART): a randomised controlled trialDominic Stringer, Leanne Gardner, Olivia Shaw, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 27, 2025
Desensitization With Imlifidase for HLA-Incompatible Deceased Donor Kidney Transplantation: A Delphi International Expert ConsensusLucrezia Furian, Uwe Heemann, Mats Bengtsson, et al.
Environment International|March 23, 2011
Improving health through policies that promote active travel: a review of evidence to support integrated health impact assessmentAudrey de Nazelle, Mark J Nieuwenhuijsen, Josep M Antó, et al.
Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
Trials|August 7, 2019
Update to the study protocol, including statistical analysis plan, for the multicentre, randomised controlled OuTSMART trial: a combined screening/treatment programme to prevent premature failure of renal transplants due to chronic rejection in patients with HLA antibodiesDominic Stringer, Leanne M Gardner, Janet L Peacock, et al.
Eclinicalmedicine|January 23, 2023
Optimized immunosuppression to prevent graft failure in renal transplant recipients with HLA antibodies (OuTSMART): a randomised controlled trialDominic Stringer, Leanne Gardner, Olivia Shaw, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 27, 2025
Desensitization With Imlifidase for HLA-Incompatible Deceased Donor Kidney Transplantation: A Delphi International Expert ConsensusLucrezia Furian, Uwe Heemann, Mats Bengtsson, et al.
Environment International|March 23, 2011
Improving health through policies that promote active travel: a review of evidence to support integrated health impact assessmentAudrey de Nazelle, Mark J Nieuwenhuijsen, Josep M Antó, et al.
Pageof 10